Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice

The autoimmune sialadenitis developed by non-obese diabetic (NOD) mice is considered a suitable model to study the ethiopathogenic mechanisms leading to sicca symptoms in Sjögren's syndrome (SS). Evidence supporting a neural rather than immune origin of the secretory dysfunction has been provid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Rosignoli, F.
Otros Autores: Pérez Leirós, C.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2002
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 15449caa a22015857a 4500
001 PAPER-5231
003 AR-BaUEN
005 20230518203452.0
008 190411s2002 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0036709645 
024 7 |2 cas  |a Nitric Oxide Synthase Type I, EC 1.14.13.39; Nitric Oxide Synthase, EC 1.14.13.39; Nitric Oxide, 10102-43-9; Nos1 protein, mouse, EC 1.14.13.39; Protein Isoforms; Receptors, Muscarinic; Vasoactive Intestinal Peptide, 37221-79-7 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JNRID 
100 1 |a Rosignoli, F. 
245 1 0 |a Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice 
260 |c 2002 
270 1 0 |m Pérez Leirós, C.; Departamento de Quimica Biologica, Ciudad Universitaria, Pabellón II, 1428, Buenos Aires, Argentina; email: cpleiros@qb.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Amin, A.R., Attur, M., Abramson, S.B., Nitric oxide synthase and cyclooxygenases: Distribution, regulation and intervention in arthritis (1999) Curr. Opin. Rheumatol., 11, pp. 202-209 
504 |a Bacman, S., Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome (1998) Invest. Ophthalmol. Visual Sci., 39, pp. 151-156 
504 |a Bernfeld, P., Amylase, alpha and beta (1955) Methods Enzymol., 1, pp. 149-158 
504 |a Borda, E.S., Pérez Leirós, C., Sterin Borda, L., Bracco, M.M.E., Cholinergic response of isolated rat atria to recombinant rat interferon-gamma (1991) J. Neuroimmunol., 32, pp. 53-59 
504 |a Colasanti, M., Cavalieri, E., Persichini, T., Mollace, V., Mariotto, S., Suzuki, H., Lauro, G.M., Bacterial lipopolysaccharide plus interferon-γ elicit a very fast inhibition of a Ca+2-dependent nitric oxide synthase activity in human astrocytoma cells (1997) J. Biol. Chem., 272, pp. 7582-7585 
504 |a Dawson, T.M., Snyder, S., Gases as biological messengers: Nitric oxide and carbon monoxide in the brain (1994) J. Neurosci., 14, pp. 5147-5159 
504 |a Dehaye, J.P., Christophe, J., Ernst, F., Poloczek, P., Van Bogaert, P., Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands (1985) Arch. Oral Biol., 30, pp. 827-832 
504 |a Ekström, J., Mansson, B., Tobin, G., Vasoactive intestinal peptide induces salivary secretion in the rat (1982) J. Physiol. (Lond.), 332, p. 76 
504 |a Ekström, J., Mansson, B., Tobin, G., Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity (1983) Acta Physiol. Scand., 119, pp. 169-175 
504 |a Förstermann, U., Boissel, J.P., Kleinert, H., Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III) (1998) FASEB J., 12, pp. 773-790 
504 |a Fox, R.I., Michelson, P., Approaches to the treatment of Sjögren's syndrome (2000) J. Rheumatol., 27, pp. 15-21 
504 |a Goetzl, E.J., Pankhaniya, R.R., Gaufo, G.O., Mu, Y., Xia, M., Sreedharan, S.P., Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses (1998) Ann. N. Y. Acad. Sci. U.S.A., 840, pp. 540-550 
504 |a Goin, J.C., Perez Leiros, C., Borda, E., Sterin-Borda, L., Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: Functional and pathological implications (1997) FASEB J., 10, pp. 77-83 
504 |a Hodges, R.H., Zoukhri, D., Sergheraert, C., Zieske, J.D., Dartt, D.A., Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components (1997) Invest. Ophthalmol. Visual Sci., 38, pp. 610-619 
504 |a Hu, Y., Nakagawa, Y., Purshotham, K., Humphreys-Beher, M.G., Functional changes in salivary glands of autoimmune disease-prone NOD mice (1992) Am. J. Physiol., 263, pp. E607-E614 
504 |a Hu, Y., Purushotham, K.R., Wang, P.L., Dawson, R., Humphreys-Beher, M.G., Down-regulation of β adrenergic receptors and signal transduction response in salivary glands of NOD mice (1994) Am. J. Physiol., 266, pp. G433-G443 
504 |a Humphreys-Beher, M.G., Hu, Y., Nakagawa, Y., Wang, P.L., Purushotham, K.R., Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome (1994) Adv. Exp. Med. Biol., 350, pp. 631-637 
504 |a Inoue, Y., Kaku, K., Kaneko, T., Yanahara, N., Kanno, T., Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′-5′-monophosphate (1985) Endocrinology, 116, pp. 686-692 
504 |a Jacobsson, L.T.H., Manthorpe, R., Epidemiology of Sjögren's syndrome (1995) Rheumatol. Eur., 24, pp. 46-47 
504 |a Kong, L., Robinson, C.P., Peck, A.B., Vela-Roch, N., Sakata, K.M., Dang, H., Talal, N., Humpherys-Beher, M.G., Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice (1998) Clin. Exp. Rheumatol., 16, pp. 675-681 
504 |a Kontinnen, Y.T., Platts, L.A.M., Tuominen, S., Eklund, K.K., Santavirta, N., Törnwall, J., Sorsa, T., Polak, J.M., Role of nitric oxide in Sjögren's syndrome (1997) Arthritis Rheum., 40, pp. 875-883 
504 |a Lohinai, Z., Burghardt, B., Zelles, T., Varga, G., Nitric oxide modulates salivary amylase and fluid, but not epidermal growth factor secretion in conscious rats (1999) Life Sci., 64, pp. 953-963 
504 |a Lomniczi, A., Suburo, A.M., Elverdin, J.C., Mastronardi, C.A., Diaz, S., Rettori, V., McCann, S.M., Role of nitric oxide in salivary secretion (1998) Neuroimmunomodulation, 5, pp. 226-233 
504 |a Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275 
504 |a Lundberg, J.M., Anggard, A., Fahrenkrug, J., Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion (1982) Acta Physiol. Scand., 114, pp. 329-337 
504 |a Mitsui, Y., Furuyama, S., Characterization of nitric oxide synthase in the rat parotid gland (2000) Arch. Oral Biol., 45, pp. 531-536 
504 |a Miyagawa, J., Ultrastructural and immunocytochemical submandibulitis in the non-obese diabetic (NOD) mouse (1986) Virchows Arch. (Cell. Pathol.), 51, pp. 215-225 
504 |a Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide physiology, pathophysiology and pharmacology (1991) Pharmacol. Rev., 43, pp. 109-142 
504 |a Murthy, K.S., Zhang, K.-M., Jin, J.G., Grider, J.R., Makhlouf, G.M., VIP-mediated G protein-coupled Ca+2 influx activates a constitutive NOS in dispersed gastric muscle cells (1993) Am. J. Physiol., 265, pp. G660-G671 
504 |a Nathan, C., Xie, Q.W., Regulation of biosynthesis of nitric oxide (1994) J. Biol. Chem., 269, pp. 13725-13728 
504 |a Perez Leiros, C., Goren, N., Sterin-Borda, L., Lustig, L., Borda, E.S., Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies (1994) Clin. Aut. Res., 4, pp. 249-255 
504 |a Pérez Leirós, C., Sterin Borda, L., Borda, E.S., Goin, J.C., Hosey, M.M., Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease (1997) J. Biol. Chem., 272, pp. 12989-12993 
504 |a Perez Leiros, C., Goren, N., Sterin-Borda, L., Borda, E.S., Myocardial Dysfunction in an experimental model of autoimmune myocarditis: Role of IFN gamma (1998) Neuroimmunomodulation, 4, pp. 91-97 
504 |a Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies (1999) Clin. Immunol., 90, pp. 190-195 
504 |a Perez Leiros, C., Rosignoli, F., Genaro, A.M., Sales, M.E., Sterin-Borda, L., Borda, E.S., Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands (2000) J. Aut. Nerv. Syst., 79, pp. 99-107 
504 |a Pozo, D., Delgado, M., Martínez, C., Guerrero, J.M., Leceta, J., Gomariz, R., Calvo, J.R., Immunobiology of vasoactive intestinal peptide (VIP) (2000) Immunol. Today, 21, pp. 7-11 
504 |a Robberecht, P., Waelbroeck, M., A critical view of the methods for characterization of the VIP/PACAP receptor subclasses (1998) Ann. N. Y. Acad. Sci., 865, pp. 157-163 
504 |a Roitt, I.M., Brostoff, J., Male, D., Autoimmunity and autoimmune disease (1998) Immunology, pp. 367-380. , London: Mosby International 
504 |a Rosignoli, F., Goren, N., Perez Leiros, C., Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice (2001) Clin. Immunol., 101, pp. 86-93 
504 |a Rosignoli, F., Pérez Leirós, C., Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland (2002) Eur. J. Pharmacol., 439, pp. 27-33 
504 |a Sterin-Borda, L., Pérez Leirós, C., Borda, E.S., Bracco, M.M.E., Effects of IL2 on the myocardium. Participation of the sympathetic system (1996) J. Mol. Cell. Cardiol., 28, pp. 2457-2465 
504 |a Strand, V., Talal, N., Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) (1980) Bull. Rheum. Dis., 92, pp. 212-226 
504 |a Turner, J.T., Bylund, D.B., Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: Radioligand binding assay in membrane preparations (1987) J. Pharmacol. Exp. Ther., 242, pp. 873-881 
504 |a Turner, J.T., Camden, J.M., Regulation of secretion by vasoactive intestinal peptide in isolated perfused rat submandibular glands (1992) Arch. Oral Biol., 37, pp. 281-287 
504 |a Yamamoto, H., Sims, N.E., Macauley, S.P., Nguyen, K.H.T., Nakagawa, Y., Humphreys-Beher, M.G., Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation (1996) Clin. Immunol. Immunopathol., 78, pp. 245-255 
504 |a Yamamoto, H., Ishibashi, K., Nakagawa, Y., Maeda, N., Zeng, T., Robinson, C.P., Oxford, G.E., Humphreys-Beher, M.G., Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis (1997) Scand. J. Immunol., 45, pp. 55-61 
504 |a Yamano, S., Atkinson, J.C., Baum, B.J., Fox, P.C., Salivary gland cytokine expression in NOD and normal BALB/c mice (1999) Clin. Immunol., 92, pp. 265-275 
520 3 |a The autoimmune sialadenitis developed by non-obese diabetic (NOD) mice is considered a suitable model to study the ethiopathogenic mechanisms leading to sicca symptoms in Sjögren's syndrome (SS). Evidence supporting a neural rather than immune origin of the secretory dysfunction has been provided. As both nitric oxide and vasoactive intestinal peptide (VIP) are common messengers to nervous and immune systems mediating secretory and inflammatory responses, we examined nitric oxide synthase (NOS) activity with special focus on VIP-mediated effects in salivary glands of NOD mice. We found a decreased NOS activity and expression in major salivary glands of NOD mice with respect to control mice. In addition, there was a deficient VIP-activated signaling associated with a reduced saliva and amylase secretion in response to VIP. Our results support the hypothesis of an impaired balance of neuroimmune interactions in salivary glands as early events to take place in the progressive loss of secretory function of NOD mice. © 2002 Elsevier Science B.V. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Ministerio de Salud de la Nación, MSAL, 2000-2002 
536 |a Detalles de la financiación: Fundación Alberto J. Roemmers 
536 |a Detalles de la financiación: This work was supported by grants “Beca Ramón Carrillo-Arturo Oñativia” 2000 and 2001 from Ministerio de Salud of Argentina and grant 2000-2002 from Fundación Alberto J. Roemmers. We wish to thank Dr. Livia Lustig for histological studies of NOD salivary glands and Mrs. Micaela Ricca for expert technical assistance in NOD mice management. 
593 |a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina 
593 |a Departamento de Qu, Ciudad Universitaria, Buenos Aires, Argentina 
690 1 0 |a AUTOIMMUNE SIALADENITIS 
690 1 0 |a NITRIC OXIDE 
690 1 0 |a NOD MICE 
690 1 0 |a NOS ISOFORMS 
690 1 0 |a SALIVARY GLANDS 
690 1 0 |a VIP SIGNALING 
690 1 0 |a AMYLASE 
690 1 0 |a NITRIC OXIDE SYNTHASE 
690 1 0 |a VASOACTIVE INTESTINAL POLYPEPTIDE 
690 1 0 |a AMYLASE RELEASE 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DIABETES MELLITUS 
690 1 0 |a ENZYME ACTIVATION 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a ENZYME RELEASE 
690 1 0 |a IMMUNE SYSTEM 
690 1 0 |a INFLAMMATION 
690 1 0 |a MOUSE 
690 1 0 |a NERVOUS SYSTEM 
690 1 0 |a NONHUMAN 
690 1 0 |a PAROTID GLAND 
690 1 0 |a PATHOGENESIS 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN DEFICIENCY 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a PROTEIN SECRETION 
690 1 0 |a SALIVA LEVEL 
690 1 0 |a SALIVATION 
690 1 0 |a SIALOADENITIS 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a SJOEGREN SYNDROME 
690 1 0 |a SUBMANDIBULAR GLAND 
690 1 0 |a AGE FACTORS 
690 1 0 |a ANIMALS 
690 1 0 |a FEMALE 
690 1 0 |a MALE 
690 1 0 |a MICE 
690 1 0 |a MICE, INBRED BALB C 
690 1 0 |a MICE, INBRED NOD 
690 1 0 |a NEUROIMMUNOMODULATION 
690 1 0 |a NITRIC OXIDE 
690 1 0 |a NITRIC OXIDE SYNTHASE 
690 1 0 |a NITRIC OXIDE SYNTHASE TYPE I 
690 1 0 |a PARASYMPATHETIC FIBERS, POSTGANGLIONIC 
690 1 0 |a PROTEIN ISOFORMS 
690 1 0 |a RECEPTORS, MUSCARINIC 
690 1 0 |a SALIVARY GLANDS 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a SJOGREN'S SYNDROME 
690 1 0 |a VASOACTIVE INTESTINAL PEPTIDE 
650 1 7 |2 spines  |a SALIVA 
700 1 |a Pérez Leirós, C. 
773 0 |d 2002  |g v. 130  |h pp. 109-116  |k n. 1-2  |p J. Neuroimmunol.  |x 01655728  |w (AR-BaUEN)CENRE-5708  |t Journal of Neuroimmunology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036709645&doi=10.1016%2fS0165-5728%2802%2900223-0&partnerID=40&md5=cba54554f6c332f01d21177759528927  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0165-5728(02)00223-0  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_01655728_v130_n1-2_p109_Rosignoli  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01655728_v130_n1-2_p109_Rosignoli  |y Registro en la Biblioteca Digital 
961 |a paper_01655728_v130_n1-2_p109_Rosignoli  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 66184